Indoco Remedies

Mumbai, India Founded: 1947 • Age: 79 yrs
APIs manufacturing and formulation services are provided in therapeutic segments.
Annual revenue $192.3M Latest available
Total funding - 1 rounds
Employees 6050 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Indoco Remedies

Indoco Remedies is a company based in Mumbai (India) founded in 1947. The company has 6,050 employees as of March 31, 2024. Indoco Remedies has completed 2 acquisitions, including FPP Holding Company and Florida Pharmaceutical Products. Indoco Remedies operates in a competitive market with competitors including Almac Group, Concord Biotech, BDR Pharmaceuticals Internationals, Aurobindo Pharma and Asymchem, among others.

  • Headquarter Mumbai, India
  • Employees 6050 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Indoco Remedies Limited
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $192.31 M (USD)
    -8.17
    as on Mar 31, 2025
  • Net Profit
    -$8.63 M (USD)
    -174.89
    as on Mar 31, 2025
  • EBITDA
    $9.61 M (USD)
    -62.87
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    6050

    as on Mar 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Indoco Remedies

Indoco Remedies is a publicly listed company on the NSE with ticker symbol INDOCO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: INDOCO · Sector: Health technology · India

People of Indoco Remedies

Headcount 5000-10000
Employee Profiles 49
Board Members and Advisors 1
Employee Profiles
People
Tabrez Shaikh
Sr. Manager - ARD
People
Parag Shetye
Sr. GM Purchase
People
Parikshit Vedak
Senior Manager (techno Commercial Support)
People
Manish Pandey
Sr. Officer

Unlock access to complete

Board Members and Advisors
people
Suresh G. Kare
Chairman

Unlock access to complete

Funding Insights of Indoco Remedies

Investors in Indoco Remedies

Indoco Remedies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Baring Private Equity Partners.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity firm focusing on buyouts and investments in multiple sectors
Locked Locked Locked
Premium access

Investor details for Indoco Remedies

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Indoco Remedies

Indoco Remedies has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include FPP Holding Company and Florida Pharmaceutical Products.

Investments
Premium access

Investment portfolio details for Indoco Remedies

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Generic solid and liquid dosage forms are manufactured.
Locked Locked 1999 Locked
Generic pharmaceutical products are distributed and marketed through specialized services.
Locked Locked 0 Locked
Premium access

Complete acquisition details for Indoco Remedies

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Indoco Remedies

Premium access

Detailed financials for Indoco Remedies

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Indoco Remedies Comparisons

Indoco Remedies Primary company
Description
APIs manufacturing and formulation services are provided in ...
Location
Mumbai, India
Founded Year
1947
Annual Revenue
$192.31 M (USD)
Net Profit
-$8.63 M (USD)
EBITDA
$9.61 M (USD)
Employees
6,050
As of 2024
Premium access

Peer comparison for Indoco Remedies

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Indoco Remedies

Indoco Remedies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Concord Biotech, BDR Pharmaceuticals Internationals, Aurobindo Pharma and Asymchem, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Integrated CDMO services for biopharma R&D and manufacturing are offered.
Locked Locked Locked
APIs and enzymes are manufactured through fermentation by the CDMO.
Locked Locked Locked
APIs and finished products are developed and manufactured.
Locked Locked Locked
Generic biocatalytic solutions are provided for pharmaceutical applications.
Locked Locked Locked
APIs and peptides are developed and manufactured by Asymchem.
Premium access

Detailed competitors of Indoco Remedies

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Indoco Remedies

Premium access

Complete news archive for Indoco Remedies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indoco Remedies

Indoco Remedies was founded in 1947 and raised its 1st funding round 65 years after it was founded.

Indoco Remedies is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Mar 31, 2024, the latest employee count at Indoco Remedies is 6,050.

Annual revenue of Indoco Remedies is $192.31M as on Mar 31, 2025.

Indoco Remedies was founded in 1947 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where active pharmaceutical ingredients (APIs) are manufactured alongside formulation services. Coverage includes therapeutic areas such as gastro-intestinal, respiratory, anti-infective, stomatologicals, ophthalmic, nutritionals, cardiovascular, anti-diabetics, and pain management. Leadership is provided by managing directors Sundeep V Bambolkar and Aditi Kare Panandikar.

Indoco Remedies's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

Yes, Indoco Remedies is publicly traded on NSE under the ticker symbol INDOCO.

Indoco Remedies has made 2 acquisitions, including FPP Holding Company, and Florida Pharmaceutical Products.

Indoco Remedies has 1 investor. Key investors include Baring Private Equity Partners.

The ticker symbol of Indoco Remedies is INDOCO on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available